Daniel Abbotoy

Roswell Park Comprehensive Cancer Center

Papers

Total Citations

H-Index

About

Daniel Abbotoy is a urologic oncologist whose research focuses on advancing surgical approaches for kidney cancer, particularly renal-cell carcinoma. His work centers on comparing minimally invasive techniques—such as laparoscopic and robotic surgery—against traditional open procedures to improve patient outcomes. In his landmark 2016 study, "Outcomes of Minimal Invasive vs Open Radical Nephrectomy for the Treatment of Locally Advanced Renal-Cell Carcinoma," Abbotoy demonstrated that minimally invasive nephrectomy offers comparable oncologic control to open surgery for locally advanced disease, while potentially reducing recovery times and complications. This paper, with 47 citations, has influenced surgical decision-making in complex cases. He further expanded this evidence in "Minimally invasive cytoreductive nephrectomy: a multi-institutional experience" (21 citations), showing that these techniques are feasible and safe even in the challenging setting of metastatic kidney cancer requiring cytoreduction. Abbotoy’s contributions have helped shift the paradigm toward less invasive options without compromising cancer outcomes, making him a key voice in urologic oncology. His work is essential reading for surgeons and researchers seeking to optimize surgical care for renal-cell carcinoma patients.